Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to ...

Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical services, is pleased to ...

Neuraly and Enigma Biomedical have signed an agreement for PMI04, a positron emission tomography (PET) imaging biomarker for ...

GE HealthCare is researching imaging tech for improved diagnosis and treatment of patients with cancer and neurodegenerative ...

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

The integration of Polarean’s Xenon MRI platform into SimonMed’s facilities represents a new business opportunity to expand the availability of functional lung imaging. This collaboration underscores ...

This is just a sampling of medical advancements in 2024 chosen for their common presence in the American population. It is ...

Sutter Health, OSF HealthCare, University Hospitals and others are entering expensive, long-term partnerships for key devices ...

Rising adoption of companion animals and demand for ultrasound as quick and affordable as quick and affordable imaging tool for <a target= ...

Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...

Several ASX companies understand the importance of early detection and treatment of cancer and are working to improve ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...